<DOC>
	<DOCNO>NCT02709538</DOCNO>
	<brief_summary>To evaluate long term safety efficacy GSP 301 NS compare 2 placebo NS formulation treatment perennial allergic rhinitis ( patient 12 year age old )</brief_summary>
	<brief_title>Long Term Safety Efficacy Fixed Dose Combination GSP 301 Nasal Spray ( NS ) Treatment Perennial Allergic Rhinitis ( PAR )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<criteria>1 . Aged â‰¥12 year older inclusive either sex . 2 . Documented clinical history PAR ( least 2 year precede Screening Visit [ Visit 1 ] ) exhibit document positive skin prick test ( wheal diameter least 3 mm great negative diluent control wheal ) least 1 allergen know induce PAR . Documentation positive result within 12 month prior Screening Visit ( Visit 1 ) acceptable . 1 . Pregnant lactating woman . 2 . History anaphylaxis and/or severe local reaction ( ) skin test . 3 . History positive test HIV , Hepatitis B Hepatitis C infection . 4 . Documented evidence acute significant chronic sinusitis chronic purulent postnasal drip . 5 . Subjects active pulmonary disorder infection . 6 . Subjects posterior subcapsular cataract glaucoma</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>